As the premier China-based manufacturer, we recognize the shifting dynamics in the botanical market. Horse Chestnut Extract (Aesculus hippocastanum) is no longer just a traditional remedy; it is a critical component in advanced venotonic pharmaceutical formulations and premium dermocosmetics.
Global demand is driven by the aging population in developed markets, specifically targeting venous insufficiency. Procurement professionals now prioritize Standardized Escin Content (10%-20%) over raw material weight, demanding rigorous HPLC verification and heavy metal screening to meet EU and FDA compliance.
Our facility utilizes smart-extraction technology. By integrating IoT monitoring in our drying and solvent recovery stages, we ensure maximum purity and consistent bioactivity. This industrial evolution allows us to offer 30% higher efficiency in extraction yields compared to traditional legacy plants.
We provide standardized 20% Aescin USP/EP grade, validated by third-party HPLC testing for every batch.
We operate under strict GAP (Good Agricultural Practices) and maintain direct ownership of traceable raw material sources.
With our automated warehouse management system, we maintain a 15-day lead time for standard bulk botanical orders globally.